Novo Nordisk (NVO) has launched its weight-loss drug Wegovy in Thailand, Reuters reported on Monday, citing an executive of ...

Wegovy's launch in Thaliand comes nearly a month after Eli Lilly launched its obesity management drug Mounjaro in India at ...

Novo Nordisk has launched its popular weight-loss drug Wegovy in Thailand, marking its first entry into the Southeast Asian market. The drug, seen as a game-changer, is part of Novo Nordisk's efforts ...

Novo Nordisk's Wegovy, a weight loss drug, will soon be accessible to US customers via telehealth platforms like Hims & Hers, LifeMD, and Ro, offering a reduced monthly price of $449. Novo Nordisk ...

The companies will sell the drug at a reduced price of $499 a month. Consumers looking to start the popular weight loss drug Wegovy but lacking insurance coverage will soon have a new option.

By Dani Blum I’ve reported on Ozempic since 2022. New research shows that semaglutide, the compound in the weight-loss drug Wegovy, could treat an increasingly common liver disease. The study ...

In the past two weeks, as prescription volumes have remained sluggish, analysts cut first-quarter sales estimates for Wegovy by about 5%. - Shelby Knowles/Bloomberg News Novo Nordisk sparked the ...

Novo Nordisk is expanding access to its GLP-1 drug Wegovy via telehealth, partnering with Hims and Hers, Ro, and LifeMD. Patients using these telehealth platforms can now consult doctors and ...

Wegovy, the popular weight-loss drug from Novo Nordisk, will be available through several leading telehealth providers, beginning this week. The company’s announcement comes as many compounding ...

The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial, according to the findings published Wednesday in the New England ...

The Company is working with Hims & Hers Health, Inc, LifeMD, and Ro to offer all doses of Wegovy through Novo’s direct-to-patient program NovoCare Pharmacy. Novo Nordisk is collaborating with ...